Attention: open in a new window. E-mailPrintPDF
Biomed is investing PLN600,000 in tripling the output capacity for oncological drugs by September 2018, and it is also in talks with potential buyers of rights for the probiotic brand…

Order subscription to read this article




Order at
Order from our partners:

Call us:

Find us: